INI-CET EXAM -2025
Pharmacology
Easy

Which regimen is considered the preferred treatment for cryptococcal meningitis?

Appeared in: INI-CET EXAM -2025

Explanation

  • The standard of care for the initial (induction) phase of cryptococcal meningitis is combination therapy.
  • This regimen involves a lipid formulation of Amphotericin B (like liposomal) plus Flucytosine.
  • This combination is synergistic, leading to faster clearance of the fungus from the cerebrospinal fluid (CSF) and improved clinical outcomes compared to monotherapy.
  • The induction phase typically lasts for at least two weeks, followed by consolidation and maintenance therapy, usually with fluconazole.

Why Other Options Were Wrong

  • Option A: This is not the preferred primary combination. Flucytosine is the recommended partner for Amphotericin B during the induction phase due to superior synergistic activity.
  • Option B: Fluconazole monotherapy is not potent enough for the initial induction phase of cryptococcal meningitis and is associated with high rates of treatment failure.
  • Option C: While Liposomal Amphotericin B is a key component, using it alone (monotherapy) is less effective than combining it with flucytosine. Combination therapy leads to faster fungal clearance and better outcomes.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Flowchart: Illustrating the three phases of cryptococcal meningitis treatment (Induction, Consolidation, Maintenance) with the recommended drugs and durations for each phase.
  • Visual 2: Infographic: Comparing the mechanisms of action of Amphotericin B, Flucytosine, and Fluconazole in treating fungal infections.
Clinical Relevance
  • Nursing practice connection: Knowing Pharmacological treatment of cryptococcal meningitis helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
  • Prompt initiation of the correct induction therapy (Amphotericin B + Flucytosine) is critical in managing cryptococcal meningitis to reduce the high risk of mortality and permanent neurological damage, such as vision loss, hearing loss, and cognitive impairment.
  • Nurses must closely monitor patients for drug toxicities, especially the nephrotoxicity of Amphotericin B and the bone marrow suppression caused by Flucytosine. Regular monitoring of renal function and complete blood counts is essential.
  • Management of increased intracranial pressure (ICP) through therapeutic lumbar punctures is a key nursing and medical intervention that significantly impacts patient outcomes in cryptococcal meningitis.
How to Approach the Question
  • Identify the core of the question: It asks for the 'preferred treatment' for a specific disease, 'cryptococcal meningitis'.
  • Recognize that treatment for severe infections like this often involves multiple phases. The 'preferred treatment' usually refers to the initial, most aggressive phase (induction).
  • Recall or look up the standard treatment guidelines for opportunistic infections. The combination of Amphotericin B and Flucytosine is the gold standard for induction therapy for cryptococcal meningitis.
  • Evaluate each option against this standard. Eliminate options used for other phases (like fluconazole for maintenance) or suboptimal regimens (like monotherapy).
  • Select the option that represents the recommended first-line induction therapy, which is the combination of Liposomal Amphotericin B and Flucytosine.
Concept Tested & Keywords
  • Concept Tested: Pharmacological treatment of cryptococcal meningitis
  • Stem keywords: cryptococcal meningitis, preferred treatment, regimen
  • Lead-in keywords: Which

Question ID

QYye-KwRMnwV-uLqLwifhT

Practise the full INI-CET EXAM -2025

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Antimicrobial Drugs Questions

More INI-CET EXAM -2025 Questions